The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
CD44 is a cell surface HA-binding glycoprotein that is overexpressed to some extent by almost all tumors of epithelial origin and plays an important role in tumor initiation and metastasis. CD44 is a compelling marker for cancer stem cells of many solid malignancies. In addition, interaction of HA a...
Saved in:
Main Authors: | Ranjeeta Thapa (Author), George D. Wilson (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
by: Gul-, et al.
Published: (2021) -
CD44-Targeted Nanocarrier for Cancer Therapy
by: Prashant Kesharwani, et al.
Published: (2022) -
CD44‐targeted chimeric antigen receptor‐T eradicates acute myeloid leukaemic stem cells
by: Linah A. Shahoumi
Published: (2022) -
CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
by: Weiyan Hou, et al.
Published: (2022) -
miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44
by: Shang-Gin Wu, et al.
Published: (2024)